| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |